Naoise Gaffney brings robust experience as a patent attorney and professor to the European law firm, and will lead the firm’s UPC practice. Already registered?

LSIPR sister title releases USA Patents Rankings, divided into categories of non-contentious and contentious work | Listing identifies the go-to firms and individuals for prosecution, litigation and ...

Former DLA Piper partner Melissa Harwood joins firm’s chemistry and life sciences team | Brings experience in biotechnology, therapeutics, and chemical industries. If you don't have a login or your ...

29 August 2024 Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the ...

15 February 2024 Judge says UK courts should depart from a European precedent following Brexit | MSD counsel says appeal had ...

Five-strong team to open new location in the spring | Office will be led by experienced litigators and patent specialists ...

Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma ...

Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.

Court cites lack of inventiveness and failure to meet reproducibility standards | Decision part of broader international litigation with mixed rulings | Generics still barred from selling products ...